Detalhe da pesquisa
1.
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma.
Oncologist
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530254
2.
Subsequent locoregional therapy prolongs survival in progressive hepatocellular carcinoma patients under lenvatinib treatment.
J Formos Med Assoc
; 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310071
3.
Switching monopolar radiofrequency ablation improves long-term outcomes of medium-sized hepatocellular carcinoma.
Eur Radiol
; 31(11): 8649-8661, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895858
4.
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.
J Formos Med Assoc
; 120(4): 1051-1060, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33199101
5.
Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma.
Mol Carcinog
; 59(11): 1269-1279, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32914490
6.
Smoking and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase.
Hepatology
; 69(4): 1412-1425, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30382583
7.
Prolonged post-ablation fever may predict one-year tumor recurrence in hepatocellular carcinoma after radiofrequency ablation.
Int J Hyperthermia
; 37(1): 1008-1015, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32814458
8.
The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients.
J Formos Med Assoc
; 119(2): 635-643, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495543
9.
Timely eradication of HCV viremia by PegIFN/RBV is crucial in prevention of post RFA recurrence in CHC-HCC patients.
J Formos Med Assoc
; 118(8): 1239-1246, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30581103
10.
Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.
Cancer
; 123(20): 3966-3976, 2017 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28662289
11.
Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.
Mol Carcinog
; 56(2): 425-435, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27254796
12.
Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma.
Hepatology
; 64(3): 720-31, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27228506
13.
Development of risk scoring system for stratifying population for hepatocellular carcinoma screening.
Hepatology
; 61(6): 1934-44, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25418332
14.
Functional genomics identified a novel protein tyrosine phosphatase receptor type F-mediated growth inhibition in hepatocarcinogenesis.
Hepatology
; 59(6): 2238-50, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24470239
15.
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial.
Hepatology
; 60(5): 1697-707, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24996197
16.
Increased regulatory T cells in patients with liver cirrhosis correlated with hyperbilirubinemia and predict bacterial complications.
J Gastroenterol Hepatol
; 30(4): 775-83, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25250558
17.
Differences in liver fibrosis between patients with chronic hepatitis B and C: evaluation by acoustic radiation force impulse measurements at 2 locations.
J Ultrasound Med
; 34(5): 813-21, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25911714
18.
Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers.
Mol Carcinog
; 53(1): 58-66, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22911910
19.
Adjuvant therapy for hepatocellular carcinoma after curative treatment.
Dig Dis
; 32(6): 747-54, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25376293
20.
Locoregional treatment improves overall survival for liver cancer during second-line regorafenib or immune checkpoint inhibitor.
Am J Cancer Res
; 14(3): 1306-1315, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38590407